Cara Therapeutics (NASDAQ: CARA)
Cara Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Cara Therapeutics Company Info
CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.
News & Analysis
7 Steps to Investing in Marijuana Stocks
Here are seven steps to investing in the high-flying cannabis industry.
Is Cara Therapeutics Stock a Buy After Its First FDA Drug Approval
There's good news at long last for the beaten-down biotech stock.
Why Cara Therapeutics Shot Higher Today
The biotech gets an important nod from a top regulator.
Is Cara Therapeutics a Buy for Summer 2021?
The future of this troubled clinical-stage biotech rests on a single drug candidate that management hopes will treat an extremely common condition.
Is Cara Therapeutics a Buy?
Maybe, if you're itching to speculate.
Why Cara Therapeutics Stock Is Crashing Today
The company reported disappointing results from a phase 2 study.
Why Cara Therapeutics Stock Is Soaring Higher Today
The biotech stock is being added to an important small-cap index.
Better Buy: GW Pharmaceuticals vs. Cara Therapeutics
Both of these biotechs could have big catalysts on the way.
Valuation
Earnings Transcripts
Cara Therapeutics, inc (CARA) Q3 2021 Earnings Call Transcript
CARA earnings call for the period ending September 30, 2021.
Cara Therapeutics, inc (CARA) Q2 2021 Earnings Call Transcript
CARA earnings call for the period ending June 30, 2021.
Cara Therapeutics Inc (CARA) Q1 2021 Earnings Call Transcript
CARA earnings call for the period ending March 31, 2021.
Cara Therapeutics Inc (CARA) Q4 2020 Earnings Call Transcript
CARA earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.